Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hartmann

Showing results (191-200 of 626) with videos related to

Pageof 63
Sort By:
Archiv Der Pharmazie|February 1, 1990
[Antiestrogenic N-(4-hydroxyphenyl)-n-(1,1,1,-trifluoro-2-propyl)-4- hydroxybenzamides: influence of hydrophobic groups substituted in the ortho-position of the benzamide-fragment on activity]R W Hartmann, H D vom Orde, H Schönenberger
Journal of Medicinal Chemistry|September 1, 1985
Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanesR W Hartmann, W Schwarz, A Heindl, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 30, 1998
[Treatment of stage IIIB loco-regionally advanced non-small-cell bronchial carcinomas with radiation and interferon-beta. Preliminary results of a phase II study]J Bund, K Eberhardt, W Hartmann, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 19, 2004
Synthesis of hydroxy derivatives of highly potent non-steroidal CYP 17 inhibitors as potential metabolites and evaluation of their activity by a non cellular assay using recombinant human enzymeTilman U Hutschenreuter, Peter B Ehmer, Rolf W Hartmann
Journal of Medicinal Chemistry|July 1, 1984
Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrolsR W Hartmann, A Heindl, W Schwarz, et al.
Bioorganic & Medicinal Chemistry|July 15, 2000
Synthesis of N-substituted piperidine-4-(benzylidene-4-carboxylic acids) and evaluation as inhibitors of steroid-5alpha-reductase type 1 and 2F Picard, E Baston, W Reichert, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|April 10, 2003
6-Substituted 3,4-dihydro-naphthalene-2-carboxylic acids: synthesis and structure-activity studies in a novel class of human 5alpha reductase inhibitorsEckhard Baston, Ola I A Salem, Rolf W Hartmann
Molecular Informatics|July 28, 2016
Predicting Putative Inhibitors of 17β-HSD1Lennart Heinzerling, Rolf W Hartmann, Martin Frotscher, et al.
Archiv Der Pharmazie|April 1, 2003
Cyclohex-1-ene carboxylic acids: synthesis and biological evaluation of novel inhibitors of human 5 alpha reductaseEckhard Baston, Ola I A Salem, Rolf W Hartmann
Journal of Medicinal Chemistry|September 1, 1991
New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivativesH Bayer, C Batzl, R W Hartmann, et al.
Pageof 63

Showing results (191-200 of 626) with videos related to

Sort By:
Pageof 63
Archiv Der Pharmazie|February 1, 1990
[Antiestrogenic N-(4-hydroxyphenyl)-n-(1,1,1,-trifluoro-2-propyl)-4- hydroxybenzamides: influence of hydrophobic groups substituted in the ortho-position of the benzamide-fragment on activity]R W Hartmann, H D vom Orde, H Schönenberger
Journal of Medicinal Chemistry|September 1, 1985
Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanesR W Hartmann, W Schwarz, A Heindl, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 30, 1998
[Treatment of stage IIIB loco-regionally advanced non-small-cell bronchial carcinomas with radiation and interferon-beta. Preliminary results of a phase II study]J Bund, K Eberhardt, W Hartmann, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 19, 2004
Synthesis of hydroxy derivatives of highly potent non-steroidal CYP 17 inhibitors as potential metabolites and evaluation of their activity by a non cellular assay using recombinant human enzymeTilman U Hutschenreuter, Peter B Ehmer, Rolf W Hartmann
Journal of Medicinal Chemistry|July 1, 1984
Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrolsR W Hartmann, A Heindl, W Schwarz, et al.
Bioorganic & Medicinal Chemistry|July 15, 2000
Synthesis of N-substituted piperidine-4-(benzylidene-4-carboxylic acids) and evaluation as inhibitors of steroid-5alpha-reductase type 1 and 2F Picard, E Baston, W Reichert, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|April 10, 2003
6-Substituted 3,4-dihydro-naphthalene-2-carboxylic acids: synthesis and structure-activity studies in a novel class of human 5alpha reductase inhibitorsEckhard Baston, Ola I A Salem, Rolf W Hartmann
Molecular Informatics|July 28, 2016
Predicting Putative Inhibitors of 17β-HSD1Lennart Heinzerling, Rolf W Hartmann, Martin Frotscher, et al.
Archiv Der Pharmazie|April 1, 2003
Cyclohex-1-ene carboxylic acids: synthesis and biological evaluation of novel inhibitors of human 5 alpha reductaseEckhard Baston, Ola I A Salem, Rolf W Hartmann
Journal of Medicinal Chemistry|September 1, 1991
New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivativesH Bayer, C Batzl, R W Hartmann, et al.
Pageof 63